Cognition Therapeutics to attend Jefferies Global Healthcare Conference
CGTX•CEO Lisa Ricciardi plans to attend the conference in London from November 16-19, 2026, and discuss a recent FDA meeting on endpoint selection for the planned Phase 3 zervimesine trial in dementia with Lewy bodies.
1. Conference appearance
Cognition Therapeutics CEO Lisa Ricciardi plans to attend the Jefferies Global Healthcare Conference in London from November 16-19, 2026. She will discuss a recent FDA meeting on endpoint selection for the planned Phase 3 zervimesine trial in dementia with Lewy bodies.
